Medtronic Faces False Marking Suit Over Stents
Medtronic had no right to mark its Endeavor stent system and other products with two patents declared unenforceable in court, according to a qui tam suit Promote Innovation filed Friday in the U.S. District Court for the Eastern District of Texas.
Zachariah Harrington, an attorney at Antonelli Harrington & Thompson LLP who represents the plaintiff, said the patents were found to be unenforceable in 2008, and...
Already a subscriber? Click here to login